Research: Identifying new treatment options for Burkitt lymphoma that doesn’t respond to treatment
While standard chemotherapy and rituximab cure 95% of children with Burkitt lymphoma, current treatments carry severe side effects and relapses. Researchers are using different technologies to develop targeted drugs that improve cure rates for relapsed cases.